Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
04/2008
04/01/2008US7351729 JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
04/01/2008US7351703 Which modulate the endogenous production of cyclic guanosine monophosphate (cGMP); for therapy and prophylaxis of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficency, thromboses, and/or atherosclerosis
03/2008
03/27/2008WO2008035737A1 4-nitrobenzoyl derivative having sulfoxyimino group and herbicide for rice plant
03/27/2008WO2008035023A1 Polymorphs of rimonabant
03/27/2008WO2008034863A2 Sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
03/27/2008WO2008005489A3 1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
03/27/2008WO2008004088A3 Iron-copper co-catalyzed process for carbon-carbon or carbon-heteroatom bonding
03/27/2008US20080076815 Sulfonamide or sulfonimide functional indazole or indole compounds such as N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydryoxyethyl]phenyl]methanesulfonamide; diabetes, obesity, hyperlipidemia and urinary incontinence
03/27/2008US20080076814 Hexahydro-Cyclooctyl Pyrazole Cannabinoid Modulators
03/27/2008US20080076802 Vinylaminopyrazole derivatives as pesticides
03/27/2008US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
03/27/2008US20080076767 Controlling cell proliferation, cell differentiation,autoimmune disease; N-[4-(3-amino-1,2-benzisoxazol-4-yl)phenyl]-N'-(3-methylphenyl)urea; 2-[4-(3-amino-1H-indazol-4-yl)phenyl]-N-(3-chlorophenyl)acetamide; N-[4-(3-amino-1,2-benzisothiazol-4-yl)phenyl]-N'-(3,5-dimethylphenyl)urea; anticarcinogenic
03/27/2008CA2662484A1 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
03/26/2008EP1903045A1 Pyrazolopyrimidine derivative
03/26/2008EP1902034A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
03/26/2008EP1902033A1 Method for producing carboxamides
03/26/2008EP1902032A1 Pharmaceutical compounds
03/26/2008EP1902031A1 Cathepsin cysteine protease inhibitors
03/26/2008EP1902017A1 Antiviral compounds and methods
03/26/2008EP1901731A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
03/26/2008CN101151251A Substituted pyrazolyl oxyphenyl derivatives used as herbicides
03/26/2008CN100376580C Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
03/26/2008CN100376565C Method for preparing fused oxazinones
03/26/2008CN100376551C Semicarbazone synthesis method
03/25/2008US7348440 Mitotic kinesin inhibitors
03/25/2008US7348359 Retinoid X receptor modulators
03/25/2008US7348350 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesirable microorganisms
03/25/2008US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
03/25/2008US7348338 PPAR active compounds
03/20/2008WO2008033455A2 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
03/20/2008WO2008032330A2 Improved process for rimonabant
03/20/2008WO2008031811A1 Nitrate esters of aminoalcohols
03/20/2008WO2008031534A1 Insecticidal compounds
03/20/2008WO2008008954A3 Isothiocyanates and glucosinolate compounds and anti-tumor compositios containing same
03/20/2008WO2007144769A3 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
03/20/2008WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives
03/20/2008WO2007020098A8 Method for producing substituted pyrazoles
03/20/2008US20080071092 Oxidation color dye; reavcting a hydrazine compound
03/20/2008US20080070968 1-(4-fluoro-phenyl)-8-(4-methyl-benzyl)-1,4,5,6,7,8-hexahydro-cycloheptapyrazole-3-carboxylic acid (1,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-amide; antidepressant, anxiolytic; nervous system disorders, metabolic disorders, obesity
03/20/2008US20080070967 facilitates handling; 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid; methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate; crystallization; industrial scale
03/20/2008US20080070959 Guanylhydrazone compounds, compositions, methods of making and using
03/20/2008US20080070937 Small molecule inhibitors of kynurenine-3-monooxygenase
03/20/2008US20080070933 Purine, Pyrimidine, and Azaindole Derivatives
03/20/2008US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
03/20/2008US20080069789 N-(2-Thiophen-2-ylethyl)benzene-1,4-diamine; hair dye; very strong and sparingly selective coloration of keratin fibers, light fast, avoiding the degradation of the fibers
03/20/2008DE102006030479A1 Indazolderivate Indazole derivatives
03/20/2008CA2663129A1 Nitrate esters of aminoalcohols
03/19/2008EP1900728A1 Pharmaceutical composition comprising pyrazolone derivative
03/19/2008EP1899309A1 Heterocyclic compounds as agonists for the thyroid receptor
03/19/2008EP1899304A1 5-amino-1h-pyrazole-3-carboxylic acid derivatives as agonists for the g-protein coupled receptor (gpcr) rup38 for the treatment of metabolic-related disorders thereof
03/19/2008EP1824338B1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides
03/19/2008CN101146777A Carboxanilides as microbiocides
03/19/2008CN101146773A 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents
03/18/2008US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide
03/18/2008US7345058 Pyrazoles
03/18/2008CA2359089C Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions et dyeing methods
03/18/2008CA2277893C 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides
03/13/2008WO2008030618A1 Benzo-fused compounds for use in treating metabolic disorders
03/13/2008WO2008028937A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
03/13/2008WO2007068370A3 Pyrazolyl carboxamides
03/13/2008US20080064734 Mixture with other active materials; controlling glucose metabolism; diabetes
03/13/2008US20080064731 Remedy for chronic disease
03/13/2008US20080064698 1-Phenyl and 1-Pyridylpyrazole Derivatives and Their Use as Pesticides
03/13/2008US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency
03/13/2008US20080064688 Anti-inflammatory medicaments
03/13/2008US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea
03/13/2008US20080064684 Sub-type selective serotonin receptor agonists; antidepressants; schizophrenia, Alzheimer's Disease, Parkinson's Disease; alkylation or amidation of the heterocyclylbenzazole with an alkylhalide or acylhalide
03/13/2008US20080064682 1,5-diaryl-3-N-heterocycylcarbonylpyrazoles; antiagglomerants that do not inhibit cyclooxygenases; antiischemic agents
03/13/2008US20080064662 Agonists having a biphenyl moiety in combination with an amide linkage at the core of the structure enhances selectivity for S1P1 receptor without causing hypotension or bradycardia; transplant rejection, autoimmune diseases; 2-Amino-N-[4-(biphenyl-4-yloxy)-phenyl]3-hydroxy-2-methyl-propionamide
03/13/2008US20080061684 Metal Complex Compound and Organic Electroluminescent Element Using the Same
03/13/2008DE102006039909A1 Verfahren zum Herstellen von 3-Dihalomethyl-pyrazol-4-carbonsäurederivaten A process for preparing 3-dihalomethyl-pyrazole-4-carboxylic acid derivatives
03/13/2008CA2662091A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions
03/12/2008EP1896438A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands
03/12/2008EP1896424A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/12/2008EP1896423A1 Method for producing carboxamides
03/12/2008CN101142207A Conversion of 2-pyrazolines to pyrazoles using bromine
03/12/2008CN101142206A Compounds, process for their preparation and use thereof
03/12/2008CN101142201A Substituted phenyl-piperazine compounds, their preparation and use in medicaments
03/12/2008CN101142172A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
03/12/2008CN101139322A Method for preparing 5-amido-1-(2,6-dichlorin-4-trifluoro methylbenzene)-3-cyano pyrazole
03/12/2008CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers
03/11/2008US7342037 Anti-inflammatory medicaments
03/11/2008US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
03/11/2008US7341607 Yellow anionic disazo dyes
03/11/2008CA2485298C Substituted pyrazolyl compounds for the treatment of inflammation
03/11/2008CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders
03/11/2008CA2351370C Method for producing 1-substituted 5- or 3-hydroxypyrazoles
03/06/2008WO2008006575A3 Method for producing alkylanilides from halobenzene derivatives
03/06/2008US20080058533 Pyranoindazole cyclic carbonates and methods of use
03/06/2008US20080058515 indazolylacrylamide derivatives are useful in the treatment of diseases associated with inappropriate SGK-1 activity
03/06/2008US20080058401 1-(2-(3,3-dimethylbutyl)-4-(trifluoromethyl)benzyl)-3-(1-methyl-1H-indazol-4-yl)urea; transient receptor potential vanilloid-1 (TRPV1) antagonist; low inhibitory activity against drug metabolism enzyme CYP3A4; antinociceptive, analgesic, antiinflammatory, antischemic agent; neuropatic pain
03/06/2008US20080058395 Fused heterocyclic inhibitors of D-amino acid oxidase
03/06/2008US20080058389 Carboxamides
03/06/2008US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds
03/06/2008US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis
03/06/2008US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties
03/06/2008US20080058313 Tetrahydro-2h-indazole pyrazole cannabinoid modulators
03/05/2008EP1893588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/05/2008EP1893583A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
03/05/2008EP1893581A1 Substituted arylpyrazoles for use against parasitites
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 256